Covid-19 vaccine: Pfizer, J&J entry could still be months away

Credit: IndiaTimes- Published on April 13, 2021
US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While Johnson & Johnson is keen to enter India and has held preliminary discussions for applying for an emergency approval recently, Pfizer...

Video credit: ABC Action News
Published 3 weeks ago -  02:18
Pfizer CEO says people 'likely' will need third COVID shot in next 12 months
Pfizer CEO Albert Bourla said that people would likely need a third shot of the Pfizer/BioNTech COVID-19 vaccine within 12 months after being fully vaccinated.

You are here


💡 newsR Knowledge: Other News Mentions





Related videos from verified sources

US infection rate hits 7-month low as vaccinations rise 02:35
Credit: Bleacher Report AOL - Published 1 day ago 


Can employers require the COVID-19 vaccine? 14:35
Credit: WCPO Cincinnati - Published 2 days ago 


Pfizer takes first steps to apply for full FDA approval of its COVID-19 vaccine 00:29
Credit: FOX 4 Now Florida - Published 2 days ago 


Related news from verified sources

US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for...
on April 13, 2021 • IndiaTimes

US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals...
on April 14, 2021 • IndiaTimes

Beijing has started to accept vaccination records from people seeking to enter China who have been inoculated in the United States with Covid-19 shots made by US...
3 weeks ago • IndiaTimes

You might like